Joseph C Devlin1, Jordan Axelrad2, Ashley M Hine3, Shannon Chang2, Suparna Sarkar4, Jian-Da Lin5, Kelly V Ruggles6, David Hudesman2, Ken Cadwell7, P'ng Loke8. 1. Department of Microbiology; Vilcek Institute of Graduate Biomedical Sciences; Institute of Systems Genetics. 2. Division of Gastroenterology and Hepatology, Department of Medicine. 3. Department of Microbiology; Division of Gastroenterology and Hepatology, Department of Medicine. 4. Department of Pathology. 5. Department of Microbiology; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; Department of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan. 6. Institute of Systems Genetics; Division of Translational Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, New York. 7. Department of Microbiology; Division of Gastroenterology and Hepatology, Department of Medicine; Skirball Institute of Biomedical Medicine. Electronic address: Ken.Cadwell@nyulangone.org. 8. Department of Microbiology; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. Electronic address: Png.Loke@nih.gov.
Abstract
BACKGROUND & AIMS: Restorative proctocolectomy with ileal pouch-anal anastomosis is a surgical procedure in patients with ulcerative colitis refractory to medical therapies. Pouchitis, the most common complication, is inflammation of the pouch of unknown etiology. To define how the intestinal immune system is distinctly organized during pouchitis, we analyzed tissues from patients with and without pouchitis and from patients with ulcerative colitis using single-cell RNA sequencing (scRNA-seq). METHODS: We examined pouch lamina propria CD45+ hematopoietic cells from intestinal tissues of ulcerative colitis patients with (n = 15) and without an ileal pouch-anal anastomosis (n = 11). Further in silico meta-analysis was performed to generate transcriptional interaction networks and identify biomarkers for patients with inflamed pouches. RESULTS: In addition to tissue-specific signatures, we identified a population of IL1B/LYZ+ myeloid cells and FOXP3/BATF+ T cells that distinguish inflamed tissues, which we further validated in other scRNA-seq datasets from patients with inflammatory bowel disease (IBD). Cell-type-specific transcriptional markers obtained from scRNA-seq was used to infer representation from bulk RNA sequencing datasets, which further implicated myeloid cells expressing IL1B and S100A8/A9 calprotectin as interacting with stromal cells, and Bacteroidales and Clostridiales bacterial taxa. We found that nonresponsiveness to anti-integrin biologic therapies in patients with ulcerative colitis was associated with the signature of IL1B+/LYZ+ myeloid cells in a subset of patients. CONCLUSIONS: Features of intestinal inflammation during pouchitis and ulcerative colitis are similar, which may have clinical implications for the management of pouchitis. scRNA-seq enables meta-analysis of multiple studies, which may facilitate the identification of biomarkers to personalize therapy for patients with IBD. The processed single cell count tables are provided in Gene Expression Omnibus; GSE162335. Raw sequence data are not public and are protected by controlled-access for patient privacy.
BACKGROUND & AIMS: Restorative proctocolectomy with ileal pouch-anal anastomosis is a surgical procedure in patients with ulcerative colitis refractory to medical therapies. Pouchitis, the most common complication, is inflammation of the pouch of unknown etiology. To define how the intestinal immune system is distinctly organized during pouchitis, we analyzed tissues from patients with and without pouchitis and from patients with ulcerative colitis using single-cell RNA sequencing (scRNA-seq). METHODS: We examined pouch lamina propria CD45+ hematopoietic cells from intestinal tissues of ulcerative colitis patients with (n = 15) and without an ileal pouch-anal anastomosis (n = 11). Further in silico meta-analysis was performed to generate transcriptional interaction networks and identify biomarkers for patients with inflamed pouches. RESULTS: In addition to tissue-specific signatures, we identified a population of IL1B/LYZ+ myeloid cells and FOXP3/BATF+ T cells that distinguish inflamed tissues, which we further validated in other scRNA-seq datasets from patients with inflammatory bowel disease (IBD). Cell-type-specific transcriptional markers obtained from scRNA-seq was used to infer representation from bulk RNA sequencing datasets, which further implicated myeloid cells expressing IL1B and S100A8/A9 calprotectin as interacting with stromal cells, and Bacteroidales and Clostridiales bacterial taxa. We found that nonresponsiveness to anti-integrin biologic therapies in patients with ulcerative colitis was associated with the signature of IL1B+/LYZ+ myeloid cells in a subset of patients. CONCLUSIONS: Features of intestinal inflammation during pouchitis and ulcerative colitis are similar, which may have clinical implications for the management of pouchitis. scRNA-seq enables meta-analysis of multiple studies, which may facilitate the identification of biomarkers to personalize therapy for patients with IBD. The processed single cell count tables are provided in Gene Expression Omnibus; GSE162335. Raw sequence data are not public and are protected by controlled-access for patient privacy.
Authors: Ingrid Arijs; Gert De Hertogh; Bart Lemmens; Leentje Van Lommel; Magali de Bruyn; Wiebe Vanhove; Isabelle Cleynen; Kathleen Machiels; Marc Ferrante; Frans Schuit; Gert Van Assche; Paul Rutgeerts; Severine Vermeire Journal: Gut Date: 2016-10-07 Impact factor: 23.059
Authors: Mitch Dowsett; Torsten O Nielsen; Roger A'Hern; John Bartlett; R Charles Coombes; Jack Cuzick; Matthew Ellis; N Lynn Henry; Judith C Hugh; Tracy Lively; Lisa McShane; Soon Paik; Frederique Penault-Llorca; Ljudmila Prudkin; Meredith Regan; Janine Salter; Christos Sotiriou; Ian E Smith; Giuseppe Viale; Jo Anne Zujewski; Daniel F Hayes Journal: J Natl Cancer Inst Date: 2011-09-29 Impact factor: 13.506
Authors: Kaushal Parikh; Agne Antanaviciute; David Fawkner-Corbett; Marta Jagielowicz; Anna Aulicino; Christoffer Lagerholm; Simon Davis; James Kinchen; Hannah H Chen; Nasullah Khalid Alham; Neil Ashley; Errin Johnson; Philip Hublitz; Leyuan Bao; Joanna Lukomska; Rajinder Singh Andev; Elisabet Björklund; Benedikt M Kessler; Roman Fischer; Robert Goldin; Hashem Koohy; Alison Simmons Journal: Nature Date: 2019-02-27 Impact factor: 49.962
Authors: Mo Xu; Maria Pokrovskii; Yi Ding; Ren Yi; Christy Au; Oliver J Harrison; Carolina Galan; Yasmine Belkaid; Richard Bonneau; Dan R Littman Journal: Nature Date: 2018-02-07 Impact factor: 49.962
Authors: Clarissa Campbell; Peter T McKenney; Daniel Konstantinovsky; Olga I Isaeva; Michail Schizas; Jacob Verter; Cheryl Mai; Wen-Bing Jin; Chun-Jun Guo; Sara Violante; Ruben J Ramos; Justin R Cross; Krishna Kadaveru; John Hambor; Alexander Y Rudensky Journal: Nature Date: 2020-04-15 Impact factor: 49.962